[Federal Register Volume 61, Number 80 (Wednesday, April 24, 1996)]
[Notices]
[Page 18124]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 96-9990]



-----------------------------------------------------------------------


DEPARTMENT OF DEFENSE

Availability of Non-Exclusive, Exclusive, or Partially Exclusive 
Licensing of U.S. Patent Application Concerning Protective Monoclonal 
Antibody Against Botulinum Neurotoxin Serotype F

AGENCY: U.S. Army Medical Research and Materiel Command, DOD.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: In accordance with 37 CFR 404.6, announcement is made of the 
availability of U.S. Patent Application SN 08/504,969, entitled 
``Protective Monoclonal Antibody Against Botulinum Neurotoxin Serotype 
F,'' and filed July 20, 1995, for licensing. This patent has been 
assigned to the United States Government as represented by the 
Secretary of the Army.

ADDRESSES: Commander, U.S. Army Medical Research and Materiel Command, 
ATTN: Command Judge Advocate, Fort Detrick, Maryland 21702-5012.

FOR FURTHER INFORMATION CONTACT:
Mr. John F. Moran, Patent Attorney, 301-619-7807 or telefax 301-619-
7714.

SUPPLEMENTARY INFORMATION: This invention is related to the production 
and use of novel neutralizing monoclonal antibodies against botulinum 
neurotoxin serotype F (BNT/F) which are completely protective in vivo 
against BNT/F, and hybridomas which produce monoclonal antibodies 
against BNT/F. The invention is directed to the antibodies, to 
processes of preparing the antibodies, to diagnostic, prophylactic, and 
therapeutic methods and compositions employing the antibodies, and to 
investigational, pharmaceutical, and other methods and compositions 
employing the antibodies.
Gregory D. Showalter,
Army Federal Register Liaison Officer.
[FR Doc. 96-9990 Filed 4-23-96; 8:45 am]
BILLING CODE 3710-08-M